DeAngelo, Daniel J., Sekeres, Mikkael A., Ottmann, Oliver ORCID: https://orcid.org/0000-0001-9559-1330, Sanz, Miguel A., Naoe, Tomoki, Taube, Tillmann, Belsack, Valerie, Ge, Miaomiao and Doehner, Hartmut 2015. Phase III randomized trial of volasertib combined with low-dose cytarabine (LDAC) versus placebo plus LDAC in patients aged >= 65 years with previously untreated, acute myeloid leukemia (AML) ineligible for intensive remission induction therapy. Clinical Lymphoma, Myeloma and Leukemia 15 , S194-S194. 10.1016/j.clml.2015.04.046 |
Official URL: http://dx.doi.org/10.1016/j.clml.2015.04.046
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Medicine |
Subjects: | R Medicine > R Medicine (General) |
Publisher: | Elsevier |
ISSN: | 2152-2650 |
Last Modified: | 02 Nov 2022 09:54 |
URI: | https://orca.cardiff.ac.uk/id/eprint/96773 |
Actions (repository staff only)
Edit Item |